A. Love et al., CHARACTERISTICS OF HEPATITIS-C VIRUS AMONG INTRAVENOUS-DRUG-USERS IN ICELAND, American journal of epidemiology, 143(6), 1996, pp. 631-636
According to antibody analysis, approximately two of every three intra
venous drug users in Iceland have become infected with hepatitis C vir
us (HCV), In this study, serum samples from 55 HCV antibody-positive i
ntravenous drug users (39 males and 16 females) were analyzed by polym
erase chain reaction, and the viral strains were grouped into genotype
s, Only three genotypes-1a, 3a, and 1b-were found among the drug users
. Of 40 persons who were positive by polymerase chain reaction, 23 (57
.5%) had type 1a, 15 (37.5%) had type 3a, and one (2.5%) had type 1b.
One serum sample was untypeable. HCV viral RNA was detectable in 84.6%
of the males and 43.7% of the females, which is a significant differe
nce between the sexes (p < 0.01), In addition, 41 randomly selected HC
V antibody-positive intravenous drug users (17 males and 24 females) w
ere tested for HCV viral RNA with a commercially available polymerase
chain reaction technique, In this subset of drug users, 76.4% of the m
ales and 33.3% of the females had detectable HCV RNA in their serum, w
hich is also a significant sex difference (p < 0.01), This study shows
that two HCV genotypes predominate among intravenous drug users in Ic
eland, and the results indicate that women eliminate virus more effect
ively than men.